Showing 361-370 of 842 results for "".
Apocrine Hidrocystoma of the Axilla
https://practicaldermatology.com/issues/october-2025/apocrine-hidrocystoma-of-the-axilla-an-illustrative-case-and-literature-review/39757/An Illustrative Case and Literature ReviewShedding Some Light on Hair Loss
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/shedding-some-light-on-hair-loss/23191/A look at the evolution of laser- and LED-assisted hair regrowth and the future of light therapy in the treatment of androgenetic alopeciaRecent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments/23510/Optimizing Dermatology Office Visits With Children and Families
https://practicaldermatology.com/topics/practice-management/optimizing-dermatology-office-visits-with-children-and-families/23897/Different ages call for different approaches when seeing pediatric patients.Why Are Dermatologists Not Writing Biologics?
https://practicaldermatology.com/topics/practice-management/why-are-dermatologists-inoti-writing-biologics/23427/Biologics have been shown to be both safe and effective for a variety of indications, so why don’t more dermatologists prescribe them?DermWireTV: AcneAlly Launches, Rosacea Insights, MC2/EPI Collaboration
https://practicaldermatology.com/videos/dermwire-tv/dermwiretv-acneally-launches-rosacea-insights-mc2epi-collaboration/19849/Dennis Porto, MD and Riyaz Farhaad, MD have launched AcneAlly.com, an online service that allows patients access to a board certified dermatologist and a standardized approach to assessment and long-term monitoring. Julie Harper, MD discusses findings from “Beyond the visible: Rosacea and psorGalderma's Future, Allergan's Bonti Buy, and Sebacia Clearance
https://practicaldermatology.com/videos/dermwire-tv/dermwiretv-galderma-s-future-allergan-s-bonti-buy-and-sebacia-clearance--xgheloga/18233/Nestle's Board says it has come to the conclusion that the future growth opportunities of Nestlé Skin Health lie increasingly outside the Group's strategic scope and expects a review of strategic options for Nestlé Skin Health to be complete by mid-2019. Allergan is acquiring Bonti forA Practical Guide to Modern Melasma Treatment
https://practicaldermatology.com/topics/pigmentary-disorders/a-practical-guide-to-modern-melasma-treatment/67256/Modern management of melasma requires an individualized approach with targeted therapies that incorporate updated knowledge of disease pathogenesis.Hidradenitis Suppurativa: Seeking More Pieces to the Puzzle
https://practicaldermatology.com/topics/rare-disease/hidradenitis-suppurativa-seeking-more-pieces-to-the-puzzle/23669/Evidence suggests that integrated approaches to care may yield best results for many patients.EGFR Inhibitor-induced Acneiform Rash: A Review of Current Management Strategies
https://practicaldermatology.com/topics/general-topics/egfr-inhibitor-induced-acneiform-rash-a-review-of-current-management-strategies/21517/